Non-Current Liabilities
Total Non-Current Liabilities
Eli Lilly Total Non-Current Liabilities decreased by 3.9% to $48.74B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 12.1%, from $43.47B to $48.74B. Over 5 years (FY 2020 to FY 2025), Total Non-Current Liabilities shows an upward trend with a 12.4% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Liabilities
CategoryLeverage
SignalLower is better
VolatilityStable
First reportedQ4 2014
Last reportedQ1 2026Apr 30, 2026
How to read this metric
High levels indicate significant long-term leverage, which may increase financial risk but also support long-term capital investment.
Detailed definition
This is the sum of all financial obligations that are not due within the next twelve months. It provides a view of the c...
Peer comparison
Standard metric for assessing long-term solvency and capital structure.
Metric ID:
total_noncurrent_liabilitiesHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $26.05B | $26.55B | $24.60B | $24.07B | $22.78B | $21.64B | $21.58B | $25.86B | $24.75B | $24.61B | $25.85B | $32.45B | $31.12B | $36.61B | $36.07B | $43.47B | $43.55B | $50.94B | $50.71B | $48.74B |
| QoQ Change | — | +1.9% | -7.4% | -2.1% | -5.3% | -5.0% | -0.3% | +19.8% | -4.3% | -0.6% | +5.0% | +25.5% | -4.1% | +17.7% | -1.5% | +20.5% | +0.2% | +17.0% | -0.5% | -3.9% |
| YoY Change | — | — | — | — | -12.5% | -18.5% | -12.3% | +7.4% | +8.6% | +13.7% | +19.8% | +25.5% | +25.7% | +48.8% | +39.5% | +34.0% | +40.0% | +39.1% | +40.6% | +12.1% |
Range$21.58B – $50.94B
CAGR+14.1%
Avg YoY Growth+19.5%
Median YoY Growth+22.6%
Current Streak2 quarters decline
Total Non-Current Liabilities at Other Companies
Frequently Asked Questions
- What is Eli Lilly's total non-current liabilities?
- Eli Lilly (LLY) reported total non-current liabilities of $48.74B in Q1 2026.
- How has Eli Lilly's total non-current liabilities changed year-over-year?
- Eli Lilly's total non-current liabilities increased by 12.1% year-over-year, from $43.47B to $48.74B.
- What is the long-term trend for Eli Lilly's total non-current liabilities?
- Over 5 years (2020 to 2025), Eli Lilly's total non-current liabilities has grown at a 12.4% compound annual growth rate (CAGR), from $28.33B to $50.71B.
- What does total non-current liabilities mean?
- The total amount of all debts and obligations due after more than one year.